The active bone conduction hearing implant Bonebridge is a therapeutic option for hearing rehabilitation of patients with conductive and mixed hearing loss, as well as for those with unilateral sensorineural hearing loss. It has demonstrated satisfactory audiological gain, comparable to conventional hearing aids and percutaneous bone-anchored hearing implants, with low rates of surgical and postoperative...
Nine-year retrospective data on the Bonebridge implant supports its long-term audiological benefit and safety, reinforcing it as a viable option for appropriate candidates, though the retrospective design limits causal inference.
Long-term outcome data for active bone conduction implants are scarce, and this nine-year dataset helps clinicians counsel patients on durable hearing benefit and complication risk.
- 01Retrospective study spans nine years of Bonebridge active bone conduction implant use.
- 02Published in Laryngoscope Investigative Otolaryngology, adding peer-reviewed long-term evidence.
- 03Reported outcomes include both clinical (complications, revision) and audiological (hearing thresholds, speech perception) measures.
- 04Long-term follow-up data are valuable given the relatively recent introduction of active transcutaneous bone conduction systems.
- 05Retrospective single-center design limits generalizability.
The Bonebridge implant demonstrates sustained audiological benefit over a nine-year period.
studypartially supportedLong-term clinical outcomes for Bonebridge are acceptable over nine years of follow-up.
studypartially supported- PMID
- 42464995
- DOI
- 10.1002/lio2.70483.
- Journal
- Laryngoscope Investigative Otolaryngology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients who received the Bonebridge active bone conduction hearing implant
- Intervention
- Bonebridge active bone conduction hearing implant
Primary outcomes
Long-term audiological outcomes; Long-term clinical outcomes (complications, device survival)